Advertisement
Distinction between bridge and destination therapy is fading
Robust robotics, preeminence of repair, and a rosy percutaneous future
A rundown of what determines good and bad candidates
Important for those at risk for or having heart disease
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Cleveland Clinic-led trial is first large randomized study of the combo
Final outcomes report changes treatment paradigm
TAVR an acceptable alternative to surgery in patients at high surgical risk
Despite DES, restenosis remains a risk
These devices are far more than a last resort
Preventing below the knee amputation
Advertisement
Advertisement